STOCK TITAN

DATA BREACH - 23andMe Jewish & Chinese Consumers May be Affected

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Negative)
Tags
Rhea-AI Summary

23andMe (NASDAQ:ME) experienced a data breach in December 2023, impacting around 7 million users, particularly Jewish and Chinese customers. The hackers compiled genetic heritage, names, and addresses of these customers, selling the data on the dark web. The breach poses risks to affected individuals, especially from the Chinese government's tracking. 23andMe failed to inform compromised customers of the breach or the specific targeting of Jewish and Chinese individuals. Levi & Korsinsky is investigating potential compensation for affected parties.

Positive
  • None.
Negative
  • None.

NEW YORK, NY / ACCESSWIRE / May 6, 2024 / 23andMe (NASDAQ:ME) was hacked in December 2023, affecting approximately 7 million users of its genetic services website. According to a recently filed class complaint, hackers who infiltrated 23andMe's system were after the personal information of Jewish and Chinese customers, but the company hid that detail when notifying affected customers.

The hackers specifically targeted the personal genetic information of Jewish and Chinese customers and compiled that data - including genetic heritage, names, and addresses - into lists that were then sold on the dark web, but 23andMe concealed both those revelations when it announced the extent of the breach in December 2023.

According to the lawsuit, the hacker leaked a list of over 1 million Jewish customers expressly in retribution for the Israel-Hamas war. The hacker was also more than happy to leak a list of 350,000 Chinese customers upon request from a user with the alias "Wuhan."These lists generated a huge amount of interest from hackers on the dark web from all over the world and were shared and reshared an untold number of times.

The disclosure of these lists threatens the safety of those customers, including from the Chinese government, which has a long history of tracking Chinese citizens.

According to the lawsuit,to this day, 23andMe has not informed the 7 million compromised customers that their personal genetic information was disclosed on the dark web, nor has it told its Jewish and Chinese customers that they were specifically targeted.

IF YOU ARE A VULNERABLE person whose personal genetic information identifies you as having Ashkenazi Jewish heritage or Chinese ancestry, and/or live in California, Illinois, Oregon, or Alaska, please contact us to review your rights and eligibility for compensation:

https://bit.ly/3sYm8Cn

ADDITIONAL BACKGROUND:

According to a recently filed class action complaint, on Oct. 1, 2023, a hacker using the alias "Golem" leaked the 23andMe data of 1 million Ashkenazi Jews on Breach Forums, calling it "the most valuable data you'll ever see."

"Golem's explicit targeting of Jewish 23andMe users is further conveyed by his use of the character 'Gollum' from The Lord of the Rings - a creature driven by greed with ugly and outsized facial features - as his profile picture."

A few hours later, a user with the alias "Wuhan" asked Golem if he had "Chinese accounts," according to the complaint. The next day, Golem leaked the data of 7 million users, saying in the post that the customer information included phenotype and health information, photos, and identification data.

Golem listed prices for the customer profiles at $1,000 for 100 profiles, $5,000 for 1,000 profiles, $20,000 for 10,000 profiles and $100,000 for 100,000 profiles.

Interest in the leaked Jewish and Chinese information was immediate and overwhelming following an Israeli bombing of a Palestinian hospital.

23andMe attempted to shift the blame to customers, telling them the breach was a result of customers using recycled login credentials from their accounts on other websites.Further, 23andMe then waited until December to report that 7 million customers were directly affected by the breach and didn't say anything about the data being sold on the dark web or that Jewish and Chinese customers were specifically targeted.

Levi Korsinsky, LLP is investigating whether affected customers are entitled to compensation. If you have received a notice about the data breach, you may be entitled to compensation. There is no cost or obligation to participate. Follow the link below to find out more:

https://bit.ly/3sYm8Cn

Levi & Korsinsky is a nationally recognized consumer advocacy law firm that has recovered hundreds of millions of dollars against large corporations. The firm's team of over 70 extraordinary attorneys and professionals have a winning track record going against the most powerful defense attorneys in the world and know how to maximize your compensation. The firm is a 100% contingency firm - we don't get paid unless you get paid! Please visit us as www.zlk.com for more information. Attorney Advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
https://zlk.com/

SOURCE: Levi & Korsinsky, LLP



View the original press release on accesswire.com

FAQ

What happened to 23andMe in December 2023?

23andMe (NASDAQ:ME) experienced a data breach in December 2023, affecting around 7 million users, particularly targeting Jewish and Chinese customers.

What data was compromised in the breach?

The hackers compiled genetic heritage, names, and addresses of Jewish and Chinese customers, selling the data on the dark web.

What risks do the compromised customers face?

The breach poses risks to affected individuals, especially concerning the Chinese government's history of tracking Chinese citizens.

Is Levi & Korsinsky offering assistance to affected customers?

Levi & Korsinsky is investigating potential compensation for affected parties. Customers who received a notice about the breach may be entitled to compensation.

23andMe Holding Co.

NASDAQ:ME

ME Rankings

ME Latest News

ME Stock Data

82.79M
18.44M
3.65%
33.33%
3.98%
Diagnostics & Research
Pharmaceutical Preparations
Link
United States of America
SUNNYVALE